VIVUS, Inc.(NASDAQ : VVUS)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
Loading VVUS News...
Health Technology » Pharmaceuticals Other
|SHPG||Shire PLC Sponsored ADR||-0.50%||176.96||0.4%||$170.90m|
|PRGO||Perrigo Co. Plc||-0.03%||73.99||6.4%||$144.57m|
|VRX||Valeant Pharmaceuticals International, Inc.||-1.39%||9.25||14.2%||$140.56m|
|UTHR||United Therapeutics Corporation||4.32%||125.70||13.9%||$97.54m|
|JAZZ||Jazz Pharmaceuticals Plc||-1.69%||159.28||2.2%||$89.92m|
|ENDP||Endo International Plc||0.80%||11.37||8.9%||$73.90m|
|HZNP||Horizon Pharma plc||-0.71%||15.38||7.6%||$41.04m|
|ICPT||Intercept Pharmaceuticals, Inc.||-0.78%||112.35||22.3%||$34.59m|
|PRXL||PAREXEL International Corporation||0.73%||63.83||7.9%||$33.77m|
|PCRX||Pacira Pharmaceuticals, Inc.||1.04%||48.55||10.9%||$31.50m|
|GWPH||GW Pharmaceuticals PLC Sponsored ADR||0.25%||118.73||7.6%||$28.29m|
VIVUS, Inc. operates as a biopharmaceutical company engages in the development and commercialization of novel therapeutic products. It offers the Qsymia for chronic weight management, as well as STENDRA and SPEDRA for erectile dysfunction. Its development also include Tacrolimus which is for the treatment of Pulmonary Arterial Hypertension. The company was founded by Virgil A. Place on April 16, 1991 and is headquartered in Mountain View, CA.